Hemodynamic Effects of Intermittent Pneumatic Compression for Sports
NCT ID: NCT06168565
Last Updated: 2023-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2023-08-25
2023-09-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Does intermittent pneumatic compression enhance athletes blood flow?
* If yes, what pressure is better to cause this enhancement?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Intermittent Pneumatic Compression Following Exercise-induced Muscle Damaged
NCT06201260
Acute Effects of Exercises Combined With Blood Flow Restriction in Healthy Individuals
NCT04206345
Effects of Blood Flow Restriction on Post-Exercise Recovery in Amateur Runners
NCT06949995
Acute Effects of Percussion Massage Therapy in Adolescent Cyclists
NCT07206576
The Effect of Myofascial Release Technique on Sportive Performance, Balance and Injury Risk in Runners
NCT05392153
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sequence 1
Measures of end-diastolic peak velocity, systolic peak velocity, heart rate, and arterial diameter will be collected for two minutes, two minutes before, at the 8th minute after the start of the IPC administration, and two minutes after the conclusion of each IPC protocol. End-diastolic peak velocity and systolic peak velocity will be measured across different phases of the IPC cycle (all cuffs inflated, half of the cuffs inflated, and all cuffs deflated). Both the athletes and assessors will be unaware of which protocol is being carried out. All protocols will be performed with participants lying down in a supine position, on a stretcher. The moderate pressure protocol applies a pressure of 80mmHg and the high pressure protocol applies a pressure of 200mmHg.
Intermittent pneumatic compression (AirRelax)
Moderate pressure (around 80mmHg); high pressure (around 200mmHg), both applied on the lower-limbs
Sequence 2
Measures of end-diastolic peak velocity, systolic peak velocity, heart rate, and arterial diameter will be collected for two minutes, two minutes before, at the 8th minute after the start of the IPC administration, and two minutes after the conclusion of each IPC protocol. End-diastolic peak velocity and systolic peak velocity will be measured across different phases of the IPC cycle (all cuffs inflated, half of the cuffs inflated, and all cuffs deflated). Both the athletes and assessors will be unaware of which protocol is being carried out. All protocols will be performed with participants lying down in a supine position, on a stretcher. The moderate pressure protocol applies a pressure of 80mmHg and the high pressure protocol applies a pressure of 200mmHg.
Intermittent pneumatic compression (AirRelax)
Moderate pressure (around 80mmHg); high pressure (around 200mmHg), both applied on the lower-limbs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intermittent pneumatic compression (AirRelax)
Moderate pressure (around 80mmHg); high pressure (around 200mmHg), both applied on the lower-limbs
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy
* competing in soccer of track and field for at least two years
* not have performed any physical activity on the data collection day
Exclusion Criteria
* injured athletes
18 Years
26 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Maia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Filipe Silvano Pinto Maia
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Maia
Maia, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0000001231
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.